Overview
Cancer is often associated with pain and is a frequent issue in patients with chemotherapy-induced neuropathy. The participation of patients in studies and their influence on study design is important. Patient support groups have been formed for several forms of cancer, and are helpful in dispensing advice. The treatment of cancer patients must include activities of daily living and quality of life. Often, palliative care and end-of-life care are part of the disease trajectory. As this book shows, patients do not have equal access to cancer treatment around the world, and often basic issues as diagnosis, treatment are lacking.
Full Product Details
Author: Wolfgang Grisold ,
Stefan Oberndorfer ,
Guido Cavaletti
Publisher: Cambridge Scholars Publishing
Imprint: Cambridge Scholars Publishing
Edition: Unabridged edition
ISBN: 9781527560871
ISBN 10: 1527560872
Pages: 406
Publication Date: 09 February 2021
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Author Information
Dr Wolfgang Grisold is a Professor and neurology specialist with special interests including neuro-oncology, neuromuscular disease, and patient-related issues, such as pain, palliative care and advocacy. He has organized numerous conferences such as the ICNMD 2018 (Vienna), and has 250 publications, including seven books, to his credit. He is currently co-editor of Neurological Sciences. Stefan Oberndorfer, MD, is a Professor and Head of Department of Neurology at St Pölten University, Austria. He has published over 100 articles, and his main field of interest is clinical neuro-oncology. He is currently Head of the Karl Landsteiner Institute for Clinical Neurology and Neuropsychology, Austria, and serves as a Chair of the Working Committee for Neuro-Oncology of the Austrian Society for Neurology (ÖGN). Guido Cavaletti, MD, is a Professor at the University of Milano-Bicocca, Italy, and Senior Consultant Neurologist and Head of the Outpatient Clinic at the Department of Neurology of S. Gerardo University Hospital, Italy. He is the author of more than 300 journal articles mostly related to different aspects of the peripheral neurotoxicity of anticancer drugs at the preclinical and clinical levels.Riccardo Soffietti is a Professor of Neurology and Neuro-Oncology and Head of Neuro-Oncology, at the University of Turin, Italy. His research areas include designing and coordinating clinical-translational trials with new drugs and monitoring treatment effects with advanced neuroimaging. He has authored 170 papers and eight books, and is currently Executive Editor of Neuro-Oncology.
